Sahm ScreenerSaudi Stock Screenerفلتر الأسهم السعودية
Home / Nahdi Medical Co. / 2024 Annual Results

Nahdi Medical Co. 2024 Annual Results

Revenue
SAR 9.45B
Net Profit
SAR 821M
EPS
SAR 6.31
Operating Cash Flow
SAR 1.49B

Nahdi Medical Co. (4164) reported full year 2024 revenue of SAR 9.45B, up 8.4% from SAR 8.71B in 2023. Net profit came in at SAR 821M, down 8.1% year on year. Earnings per share were SAR 6.31. The company generated SAR 1.49B in operating cash flow. All figures sourced from CMA-mandated XBRL filings on the Saudi Exchange, processed by Sahm Screener.

Earnings Quality

Of every SAR 1.00 in reported net profit, SAR 1.82 arrived as operating cash flow — indicating Exceptional quality earnings with a cash conversion ratio of 1.82.

Key Financial Metrics

Metric20242023
RevenueSAR 9.45BSAR 8.71B
Net ProfitSAR 821MSAR 893M
Net Margin8.7%10.2%
ROE31.7%36.2%
EPSSAR 6.31SAR 6.87
Total AssetsSAR 6.17BSAR 5.37B
Total EquitySAR 2.59BSAR 2.46B
Total LiabilitiesSAR 3.59BSAR 2.91B
Operating Cash FlowSAR 1.49BSAR 1.37B

Year on Year Comparison

Revenue increased by 8.4% compared to 2023. Net profit decreased by 8.1%. Revenue grew but profit declined — suggesting margin pressure.

View full company profile →
View all years:
20252024202320222021

Financial data sourced from CMA-mandated XBRL filings published on the Saudi Exchange (Tadawul). Data processed and structured by Sahm Screener (sahmscreener.com). Updated nightly. Last updated: 2025-03-13.